6
MYTIGATE.COM IDENTIFY ANALYSE EVALUATE MYTIGATE Pharma Lane Risk Assessment Improving Compliance and Reducing Transport Risk

Pharma Lane Risk Assessment

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

M Y T I G AT E . C O M

IDENTIFY ANALYSE EVALUATE

MYTIGATE

Pharma Lane Risk AssessmentImproving Compliance and Reducing Transport Risk

EXPAND YOUR BUSINESS AND SHOWCASE YOUR CAPABILITIESAND COMPLIANCE TO THE WORLD

MYTIGATE is a state-of-the-art, fully digital, and free of charge platform that offers all supply chain partners (e.g. transport companies, warehouses, and handling agents) a means to demonstrate their compliance with good distribution practice guidelines and to showcase their capabilities directly to pharmaceutical manufacturers.

1 M Y T I G A T E . C O M

2

INTRODUCTION TO MYTIGATE

Since the introduction of the EU GDP Guidelines in 2013, pharma companies are required to assure quality throughout their supply chain and to conduct a risk-based selection process for their transport partners. Until now, however, many have been unable to meet these requirements.

Many pharmaceutical companies have tried to approach their supply chain partners with individual questionnaires, causing additional administrative work on the supply chain partners’ side. MYTIGATE – being an innovative, web-based service – is on track to become a new industry standard, showcasing supply chain partners’ compliance, capabilities, and certificates, and allowing pharma companies to select pharma-specific services of those supply chain partners that offer the highest quality and lowest risk.

Supply chain partners can present their different services by displaying related infrastructural and operational capabilities, certificates awarded, and additional commercial product details (example: brochures). This information is coupled with our state-of-the-art mathematical risk modelling and real-life quality data (example: temperature data loggers), making it possible to conduct a reliable, digital lane risk assessment.

With our eight roles covering all possible transport services (Road, Air, Sea, Airline Handling, Tarmac Handling, Port Terminal Operators, Warehouses, and Forwarding Services), MYTIGATE aims to be the driver for innovation and end-to-end visibility in pharma logistics.

The MYTIGATE risk management platform is a Software-as-a-Service (SaaS) that was co-created with the pharma industry, working hand in hand with global forwarders and supply chain partners to plan, monitor, and improve the quality of pharma shipments in a legally compliant and safe manner.

Operational & Infrastructural CapabilitiesWith our labels system, you can present your operational capabilities such as tempera-ture-controlled units, anti-theft risk measures, and handling of dangerous goods (DGR).

Direct Visibility to Shippers Create a global reach and new commercial

opportunities by being directly reachable by pharmaceutical companies, potential shippers,

and forwarders.

Diverse Services ProfileDisplay your full portfolio of different services and make your products visible – especially those tailored to the pharmaceutical industry.

Quality AssuranceMinimise the number of incidents and deviations and save costs on investigative CAPAs by benefiting from data loggers and quality data reports.

Certifications and ComplianceShow your compliance by attaching relevant certificates such as the EU GDP, IATA CEIV, ISO 9001, TAPA FSR, and many more certificates to your profile.

KEY FEATURES

3M Y T I G A T E . C O M

Profi le and LabelsSpecify the service profi le, served locations, and present your operational capabilities using our labels system

Certifi cates and ComplianceUpload your certifi cates and prove your compliance to international regulations and standards

Infrastructural CapabilitiesList all pharma-specifi c infra-structure capabilities from over 50 different role-specifi c items available on MYTIGATE

Risk Profi lePresent your risk profi le to pharma companies and your strengths that differentiate you from your competition

Partner Profi lesStandout by showcasing pharma-specifi c handling capabilities and services

Product Specifi cationsIntegrated product transport requirements

Lane DesignDigital lane managementprocess by assessing the different supply chain partners and selecting the ones with the best risk scores

Partner Profi lesStandout by showcasing pharma-specifi c handling capabilities and services

Product Specifi cationsIntegrated product transport requirements

Lane DesignDigital lane managementprocess by assessing the different supply chain partners and selecting the ones with the best risk scores

5

6

7

Profi le and LabelsSpecify the service profi le, served locations, and present your operational capabilities using our labels system

Certifi cates and ComplianceUpload your certifi cates and prove your compliance to international regulations and standards

Infrastructural CapabilitiesList all pharma-specifi c infra-structure capabilities from over 50 different role-specifi c items available on MYTIGATE

Risk Profi lePresent your risk profi le to pharma companies and your strengths that differentiate you from your competition

4

1

2

3

4

5

6

7

1

2

3

The MYTIGATE tool was developed by three universities: Frankfurt University of Applied Sciences, Hochschule Fulda and Hochschule RheinMain. They worked hand in hand with industry partners from the pharmaceutical industry as well as the logistics and supply chain industry:

4 M Y T I G A T E . C O M

DEVELOPMENT PARTNERS

BUSINESS PARTNERS

MYTIGATE GmbHc/o House of Logistics & MobilityBessie-Coleman-Straße 7D-60549 Frankfurt am Main

+49 (0) [email protected]

Prof. Dr. Yvonne ZieglerFounder & [email protected]

MYTIGATE GmbH is based in the Rhine-/Main area, yet by embracing a fully digital work environment, our international team spans multiple countries including Canada, Germany, Russia, and Turkey. Our offi ce is located in the House of Logistics and Mobility (HOLM) in Frankfurt, Germany. MYTIGATE commenced operations in April 2020 in order to commercialise the results of the research project „Pharma Supply Chain Risk Management“. This project started in 2017 and was funded by the LOEWE3 innovation fund of the state of Hesse in Germany and managed by Frankfurt University of Applied Sciences.

Working hand in hand with industry leaders and academic institutes, our vision is to become the quality and sustainability standard for both the pharma and the forwarder industry. To achieve this vision, we bring together the scientifi c collaborative efforts of the different parties involved, connecting academic and research knowledge with the industry.

CONTACT US

We look forward to your inquiries and are happy to offer you a free demonstration of the tool.

LinkedInmytigate.com

ABOUT US

Dr. Vincenzo UliBusiness Development [email protected]